ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of May

May 31, 2013

Zerhouni Starts Work As NIH Director

May 24, 2002

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997

Funding Opportunities.

July 19, 2002

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

NCI budget: a “Yes” to one thing means a “No” to something else, director says.

February 27, 2004